Ph3 Selin P53 Endo Carcinoma

Phase III Clinical Trial

A PHASE 3 RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND MULTICENTER TRIAL OF SELINEXOR IN MAINTENANCE THERAPY AFTER SYSTEMIC THERAPY FOR PATIENTS WITH P53 WILD-TYPE ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA (ENGOT-EN-20/GOG-3083/ XPORT-EC-042)

Indication: Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer, Endometrial Cancer
Trial Number: 05611931
Trial Status: OPEN

Learn more about this clinical trial.

Participating Locations